[
  {
    "prompt": "Generate Cypher to store medical relations from text: Famotidine-associated delirium. A series of six cases. Famotidine is a histamine H2-receptor antagonist used in inpatient settings for prevention of stress ulcers and is showing increasing popularity because of its low cost. Although all of the currently available H2-receptor antagonists have shown the propensity to cause delirium, only two previously reported cases have been associated with famotidine. The authors report on six cases of famotidine-associated delirium in hospitalized patients who cleared co\nCypher:",
    "target": "MERGE (h:Chemical {name: 'Famotidine'}) MERGE (t:Disease {name: 'delirium'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'famotidine'}) MERGE (t:Disease {name: 'delirium'}) MERGE (h)-[:INDUCES]->(t)"
  },
  {
    "prompt": "Generate Cypher to store medical relations from text: Indomethacin induced hypotension in sodium and volume depleted rats. After a single oral dose of 4 mg/kg indomethacin (IDM) to sodium and volume depleted rats plasma renin activity (PRA) and systolic blood pressure fell significantly within four hours. In sodium repleted animals indomethacin did not change systolic blood pressure (BP) although plasma renin activity was decreased. Thus, indomethacin by inhibition of prostaglandin synthesis may diminish the blood pressure maintaining effect of the stimulated \nCypher:",
    "target": "MERGE (h:Chemical {name: 'Indomethacin'}) MERGE (t:Disease {name: 'hypotension'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'indomethacin'}) MERGE (t:Disease {name: 'hypotension'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'IDM'}) MERGE (t:Disease {name: 'hypotension'}) MERGE (h)-[:INDUCES]->(t)"
  },
  {
    "prompt": "Generate Cypher to store medical relations from text: Late-onset scleroderma renal crisis induced by tacrolimus and prednisolone: a case report. Scleroderma renal crisis (SRC) is a rare complication of systemic sclerosis (SSc) but can be severe enough to require temporary or permanent renal replacement therapy. Moderate to high dose corticosteroid use is recognized as a major risk factor for SRC. Furthermore, there have been reports of thrombotic microangiopathy precipitated by cyclosporine in patients with SSc. In this article, we report a patient with SRC in\nCypher:",
    "target": "MERGE (h:Chemical {name: 'cyclosporine'}) MERGE (t:Disease {name: 'thrombotic microangiopathy'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'corticosteroid'}) MERGE (t:Disease {name: 'systemic sclerosis'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'corticosteroid'}) MERGE (t:Disease {name: 'SSc'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'corticosteroids'}) MERGE (t:Disease {name: 'systemic sclerosis'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'corticosteroids'}) MERGE (t:Disease {name: 'SSc'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'tacrolimus'}) MERGE (t:Disease {name: 'systemic sclerosis'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'tacrolimus'}) MERGE (t:Disease {name: 'SSc'}) MERGE (h)-[:INDUCES]->(t)"
  },
  {
    "prompt": "Generate Cypher to store medical relations from text: The risk and associated factors of methamphetamine psychosis in methamphetamine-dependent patients in Malaysia. OBJECTIVE: The objective of this study was to determine the risk of lifetime and current methamphetamine-induced psychosis in patients with methamphetamine dependence. The association between psychiatric co-morbidity and methamphetamine-induced psychosis was also studied. METHODS: This was a cross-sectional study conducted concurrently at a teaching hospital and a drug rehabilitation center in Mal\nCypher:",
    "target": "MERGE (h:Chemical {name: 'methamphetamine'}) MERGE (t:Disease {name: 'psychosis'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'methamphetamine'}) MERGE (t:Disease {name: 'psychotic symptoms'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'methamphetamine'}) MERGE (t:Disease {name: 'bipolar disorder'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'methamphetamine'}) MERGE (t:Disease {name: 'antisocial personality disorder'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'methamphetamine'}) MERGE (t:Disease {name: 'antisocial personality'}) MERGE (h)-[:INDUCES]->(t)"
  },
  {
    "prompt": "Generate Cypher to store medical relations from text: Cerebellar sensory processing alterations impact motor cortical plasticity in Parkinson's disease: clues from dyskinetic patients. The plasticity of primary motor cortex (M1) in patients with Parkinson's disease (PD) and levodopa-induced dyskinesias (LIDs) is severely impaired. We recently reported in young healthy subjects that inhibitory cerebellar stimulation enhanced the sensorimotor plasticity of M1 that was induced by paired associative stimulation (PAS). This study demonstrates that the deficient sen\nCypher:",
    "target": "MERGE (h:Chemical {name: 'levodopa'}) MERGE (t:Disease {name: 'dyskinetic'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'levodopa'}) MERGE (t:Disease {name: 'dyskinesias'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'levodopa'}) MERGE (t:Disease {name: 'LIDs'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'levodopa'}) MERGE (t:Disease {name: 'abnormal involuntary movements'}) MERGE (h)-[:INDUCES]->(t)"
  },
  {
    "prompt": "Generate Cypher to store medical relations from text: The function of P2X3 receptor and NK1 receptor antagonists on cyclophosphamide-induced cystitis in rats. PURPOSE: The purpose of the study is to explore the function of P2X3 and NK1 receptors antagonists on cyclophosphamide (CYP)-induced cystitis in rats. METHODS: Sixty female Sprague-Dawley (SD) rats were randomly divided into three groups. The rats in the control group were intraperitoneally (i.p.) injected with 0.9% saline (4 ml/kg); the rats in the model group were i.p. injected with CYP (150 mg/kg); an\nCypher:",
    "target": "MERGE (h:Chemical {name: 'cyclophosphamide'}) MERGE (t:Disease {name: 'cystitis'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'CYP'}) MERGE (t:Disease {name: 'cystitis'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'Cyclophosphamide'}) MERGE (t:Disease {name: 'cystitis'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'cyclophosphamide'}) MERGE (t:Disease {name: 'pain'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'CYP'}) MERGE (t:Disease {name: 'pain'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'Cyclophosphamide'}) MERGE (t:Disease {name: 'pain'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'cyclophosphamide'}) MERGE (t:Disease {name: 'edema'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'CYP'}) MERGE (t:Disease {name: 'edema'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'Cyclophosphamide'}) MERGE (t:Disease {name: 'edema'}) MERGE (h)-[:INDUCES]->(t)"
  },
  {
    "prompt": "Generate Cypher to store medical relations from text: Acute hepatitis associated with clopidogrel: a case report and review of the literature. Drug-induced hepatotoxicity is a common cause of acute hepatitis, and the recognition of the responsible drug may be difficult. We describe a case of clopidogrel-related acute hepatitis. The diagnosis is strongly suggested by an accurate medical history and liver biopsy. Reports about cases of hepatotoxicity due to clopidogrel are increasing in the last few years, after the increased use of this drug. In conclusion, we \nCypher:",
    "target": "MERGE (h:Chemical {name: 'clopidogrel'}) MERGE (t:Disease {name: 'hepatitis'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'clopidogrel'}) MERGE (t:Disease {name: 'hepatotoxicity'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'clopidogrel'}) MERGE (t:Disease {name: 'hepatic injury'}) MERGE (h)-[:INDUCES]->(t)"
  },
  {
    "prompt": "Generate Cypher to store medical relations from text: Bortezomib and dexamethasone as salvage therapy in patients with relapsed/refractory multiple myeloma: analysis of long-term clinical outcomes. Bortezomib (bort)-dexamethasone (dex) is an effective therapy for relapsed/refractory (R/R) multiple myeloma (MM). This retrospective study investigated the combination of bort (1.3 mg/m(2) on days 1, 4, 8, and 11 every 3 weeks) and dex (20 mg on the day of and the day after bort) as salvage treatment in 85 patients with R/R MM after prior autologous stem cell trans\nCypher:",
    "target": "MERGE (h:Chemical {name: 'dexamethasone'}) MERGE (t:Disease {name: 'peripheral neuropathy'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'dex'}) MERGE (t:Disease {name: 'peripheral neuropathy'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'Bortezomib'}) MERGE (t:Disease {name: 'peripheral neuropathy'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'bort'}) MERGE (t:Disease {name: 'peripheral neuropathy'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'Bort'}) MERGE (t:Disease {name: 'peripheral neuropathy'}) MERGE (h)-[:INDUCES]->(t)"
  },
  {
    "prompt": "Generate Cypher to store medical relations from text: Pubertal exposure to Bisphenol A increases anxiety-like behavior and decreases acetylcholinesterase activity of hippocampus in adult male mice. The negative effects of Bisphenol A (BPA) on neurodevelopment and behaviors have been well established. Acetylcholinesterase (AChE) is a regulatory enzyme which is involved in anxiety-like behavior. This study investigated behavioral phenotypes and AChE activity in male mice following BPA exposure during puberty. On postnatal day (PND) 35, male mice were exposed to \nCypher:",
    "target": "MERGE (h:Chemical {name: 'Bisphenol A'}) MERGE (t:Disease {name: 'anxiety'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'BPA'}) MERGE (t:Disease {name: 'anxiety'}) MERGE (h)-[:INDUCES]->(t)"
  },
  {
    "prompt": "Generate Cypher to store medical relations from text: Biochemical effects of Solidago virgaurea extract on experimental cardiotoxicity. Cardiovascular diseases (CVDs) are the major health problem of advanced as well as developing countries of the world. The aim of the present study was to investigate the protective effect of the Solidago virgaurea extract on isoproterenol-induced cardiotoxicity in rats. The subcutaneous injection of isoproterenol (30 mg/kg) into rats twice at an interval of 24 h, for two consecutive days, led to a significant increase in serum\nCypher:",
    "target": "MERGE (h:Chemical {name: 'isoproterenol'}) MERGE (t:Disease {name: 'cardiotoxicity'}) MERGE (h)-[:INDUCES]->(t)"
  },
  {
    "prompt": "Generate Cypher to store medical relations from text: \"Real-world\" data on the efficacy and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma who were treated according to the standard clinical practice: a study of the Greek Myeloma Study Group. Lenalidomide and dexamethasone (RD) is a standard of care for relapsed/refractory multiple myeloma (RRMM), but there is limited published data on its efficacy and safety in the \"real world\" (RW), according to the International Society of Pharmacoeconomics and Outcomes Resear\nCypher:",
    "target": "MERGE (h:Chemical {name: 'dexamethasone'}) MERGE (t:Disease {name: 'Peripheral neuropathy'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'dexamethasone'}) MERGE (t:Disease {name: 'myelosuppression'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'dexamethasone'}) MERGE (t:Disease {name: 'deep vein thrombosis'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'lenalidomide'}) MERGE (t:Disease {name: 'myelosuppression'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'Lenalidomide'}) MERGE (t:Disease {name: 'myelosuppression'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'lenalidomide'}) MERGE (t:Disease {name: 'Peripheral neuropathy'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'Lenalidomide'}) MERGE (t:Disease {name: 'Peripheral neuropathy'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'lenalidomide'}) MERGE (t:Disease {name: 'deep vein thrombosis'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'Lenalidomide'}) MERGE (t:Disease {name: 'deep vein thrombosis'}) MERGE (h)-[:INDUCES]->(t)"
  },
  {
    "prompt": "Generate Cypher to store medical relations from text: The cytogenetic action of ifosfamide, mesna, and their combination on peripheral rabbit lymphocytes: an in vivo/in vitro cytogenetic study. Ifosfamide (IFO) is an alkylating nitrogen mustard, administrated as an antineoplasmic agent. It is characterized by its intense urotoxic action, leading to hemorrhagic cystitis. This side effect of IFO raises the requirement for the co-administration with sodium 2-sulfanylethanesulfonate (Mesna) aiming to avoid or minimize this effect. IFO and Mesna were administrated \nCypher:",
    "target": "MERGE (h:Chemical {name: 'ifosfamide'}) MERGE (t:Disease {name: 'cystitis'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'Ifosfamide'}) MERGE (t:Disease {name: 'cystitis'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'IFO'}) MERGE (t:Disease {name: 'cystitis'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'ifosfamide'}) MERGE (t:Disease {name: 'hemorrhagic'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'Ifosfamide'}) MERGE (t:Disease {name: 'hemorrhagic'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'IFO'}) MERGE (t:Disease {name: 'hemorrhagic'}) MERGE (h)-[:INDUCES]->(t)"
  },
  {
    "prompt": "Generate Cypher to store medical relations from text: Risk factors and predictors of levodopa-induced dyskinesia among multiethnic Malaysians with Parkinson's disease. Chronic pulsatile levodopa therapy for Parkinson's disease (PD) leads to the development of motor fluctuations and dyskinesia. We studied the prevalence and predictors of levodopa-induced dyskinesia among multiethnic Malaysian patients with PD. METHODS: This is a cross-sectional study involving 95 patients with PD on uninterrupted levodopa therapy for at least 6 months. The instrument used was t\nCypher:",
    "target": "MERGE (h:Chemical {name: 'levodopa'}) MERGE (t:Disease {name: 'dyskinesia'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'levodopa'}) MERGE (t:Disease {name: 'Dyskinesia'}) MERGE (h)-[:INDUCES]->(t)"
  },
  {
    "prompt": "Generate Cypher to store medical relations from text: An unexpected diagnosis in a renal-transplant patient with proteinuria treated with everolimus: AL amyloidosis. Proteinuria is an expected complication in transplant patients treated with mammalian target of rapamycin inhibitors (mTOR-i). However, clinical suspicion should always be supported by histological evidence in order to investigate potential alternate diagnoses such as acute or chronic rejection, interstitial fibrosis and tubular atrophy, or recurrent or de novo glomerulopathy. In this case we repo\nCypher:",
    "target": "MERGE (h:Chemical {name: 'everolimus'}) MERGE (t:Disease {name: 'AL'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'everolimus'}) MERGE (t:Disease {name: 'amyloidosis'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'everolimus'}) MERGE (t:Disease {name: 'proteinuria'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'everolimus'}) MERGE (t:Disease {name: 'Proteinuria'}) MERGE (h)-[:INDUCES]->(t)"
  },
  {
    "prompt": "Generate Cypher to store medical relations from text: An investigation of the pattern of kidney injury in HIV-positive persons exposed to tenofovir disoproxil fumarate: an examination of a large population database (MHRA database). The potential for tenofovir to cause a range of kidney syndromes has been established from mechanistic and randomised clinical trials. However, the exact pattern of kidney involvement is still uncertain. We undertook a descriptive analysis of Yellow Card records of 407 HIV-positive persons taking tenofovir disoproxil fumarate (TDF) \nCypher:",
    "target": "MERGE (h:Chemical {name: 'tenofovir disoproxil fumarate'}) MERGE (t:Disease {name: 'acute kidney injury'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'TDF'}) MERGE (t:Disease {name: 'acute kidney injury'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'tenofovir disoproxil fumarate'}) MERGE (t:Disease {name: 'Fanconi syndrome'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'TDF'}) MERGE (t:Disease {name: 'Fanconi syndrome'}) MERGE (h)-[:INDUCES]->(t)"
  },
  {
    "prompt": "Generate Cypher to store medical relations from text: Incidence of postoperative delirium is high even in a population without known risk factors. PURPOSE: Postoperative delirium is a recognized complication in populations at risk. The aim of this study is to assess the prevalence of early postoperative delirium in a population without known risk factors admitted to the ICU for postoperative monitoring after elective major surgery. The secondary outcome investigated is to identify eventual independent risk factors among demographic data and anesthetic drugs us\nCypher:",
    "target": "MERGE (h:Chemical {name: 'thiopentone'}) MERGE (t:Disease {name: 'postoperative delirium'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'thiopentone'}) MERGE (t:Disease {name: 'Postoperative delirium'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'Thiopentone'}) MERGE (t:Disease {name: 'postoperative delirium'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'Thiopentone'}) MERGE (t:Disease {name: 'Postoperative delirium'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'thiopentone'}) MERGE (t:Disease {name: 'delirium'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'Thiopentone'}) MERGE (t:Disease {name: 'delirium'}) MERGE (h)-[:INDUCES]->(t)"
  },
  {
    "prompt": "Generate Cypher to store medical relations from text: A single neurotoxic dose of methamphetamine induces a long-lasting depressive-like behaviour in mice. Methamphetamine (METH) triggers a disruption of the monoaminergic system and METH abuse leads to negative emotional states including depressive symptoms during drug withdrawal. However, it is currently unknown if the acute toxic dosage of METH also causes a long-lasting depressive phenotype and persistent monoaminergic deficits. Thus, we now assessed the depressive-like behaviour in mice at early and long-t\nCypher:",
    "target": "MERGE (h:Chemical {name: 'methamphetamine'}) MERGE (t:Disease {name: 'depressive'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'methamphetamine'}) MERGE (t:Disease {name: 'depressive symptoms'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'methamphetamine'}) MERGE (t:Disease {name: 'depression'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'Methamphetamine'}) MERGE (t:Disease {name: 'depressive'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'Methamphetamine'}) MERGE (t:Disease {name: 'depressive symptoms'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'Methamphetamine'}) MERGE (t:Disease {name: 'depression'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'METH'}) MERGE (t:Disease {name: 'depressive'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'METH'}) MERGE (t:Disease {name: 'depressive symptoms'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'METH'}) MERGE (t:Disease {name: 'depression'}) MERGE (h)-[:INDUCES]->(t)"
  },
  {
    "prompt": "Generate Cypher to store medical relations from text: Linezolid-induced optic neuropathy. Many systemic antimicrobials have been implicated to cause ocular adverse effects. This is especially relevant in multidrug therapy where more than one drug can cause a similar ocular adverse effect. We describe a case of progressive loss of vision associated with linezolid therapy. A 45-year-old male patient who was on treatment with multiple second-line anti-tuberculous drugs including linezolid and ethambutol for extensively drug-resistant tuberculosis (XDR-TB) present\nCypher:",
    "target": "MERGE (h:Chemical {name: 'Linezolid'}) MERGE (t:Disease {name: 'optic neuropathy'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'Linezolid'}) MERGE (t:Disease {name: 'toxic optic neuropathy'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'linezolid'}) MERGE (t:Disease {name: 'optic neuropathy'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'linezolid'}) MERGE (t:Disease {name: 'toxic optic neuropathy'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'Linezolid'}) MERGE (t:Disease {name: 'optic disc edema'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'linezolid'}) MERGE (t:Disease {name: 'optic disc edema'}) MERGE (h)-[:INDUCES]->(t)"
  },
  {
    "prompt": "Generate Cypher to store medical relations from text: Resuscitation with lipid, epinephrine, or both in levobupivacaine-induced cardiac toxicity in newborn piglets. BACKGROUND: The optimal dosing regimens of lipid emulsion, epinephrine, or both are not yet determined in neonates in cases of local anaesthetic systemic toxicity (LAST). METHODS: Newborn piglets received levobupivacaine until cardiovascular collapse occurred. Standard cardiopulmonary resuscitation was started and electrocardiogram (ECG) was monitored for ventricular tachycardia, fibrillation, or Q\nCypher:",
    "target": "MERGE (h:Chemical {name: 'levobupivacaine'}) MERGE (t:Disease {name: 'cardiovascular collapse'}) MERGE (h)-[:INDUCES]->(t)"
  },
  {
    "prompt": "Generate Cypher to store medical relations from text: Incidence of heparin-induced thrombocytopenia type II and postoperative recovery of platelet count in liver graft recipients: a retrospective cohort analysis. BACKGROUND: Thrombocytopenia in patients with end-stage liver disease is a common disorder caused mainly by portal hypertension, low levels of thrombopoetin, and endotoxemia. The impact of immune-mediated heparin-induced thrombocytopenia type II (HIT type II) as a cause of thrombocytopenia after liver transplantation is not yet understood, with few li\nCypher:",
    "target": "MERGE (h:Chemical {name: 'heparin'}) MERGE (t:Disease {name: 'thrombocytopenia type II'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'heparin'}) MERGE (t:Disease {name: 'Thrombocytopenia'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'heparin'}) MERGE (t:Disease {name: 'HIT type II'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'heparin'}) MERGE (t:Disease {name: 'thrombocytopenia'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'heparin'}) MERGE (t:Disease {name: 'HIT II'}) MERGE (h)-[:INDUCES]->(t)\nMERGE (h:Chemical {name: 'heparin'}) MERGE (t:Disease {name: 'HIT'}) MERGE (h)-[:INDUCES]->(t)"
  }
]